Targeted News Service

Paul Hastings: Cyclica & ATAI Life Sciences Form Entheogenix Biosciences for Mental Health Treatment Research
November 18, 2019

NEW YORK, Nov. 18 -- Paul Hastings, a law firm, issued the following news:

Paul Hastings, a leading global law firm, announced today that the firm represented Cyclica Inc., a leading artificial intelligence-powered biotechnology company on the creation of Entheogenix Biosciences, a joint venture with ATAI Life Sciences.

Entheogenix Biosciences is aimed at advancing psychedelic research for the development of better medicines for mental health diseases such as depression . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form